ArticleTranslational cancer research2024

Exploring SSR1 as a novel diagnostic and prognostic biomarker in hepatocellular carcinoma, and its relationship with immune infiltration.

Qingyu Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.